<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rfhealth</journal-id><journal-title-group><journal-title xml:lang="ru">Здравоохранение Российской Федерации</journal-title><trans-title-group xml:lang="en"><trans-title>Health care of the Russian Federation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0044-197X</issn><issn pub-type="epub">2412-0723</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0044-197X-2024-68-5-406-411</article-id><article-id custom-type="edn" pub-id-type="custom">qwrewt</article-id><article-id custom-type="elpub" pub-id-type="custom">rfhealth-1679</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОБЛЕМЫ СОЦИАЛЬНО ЗНАЧИМЫХ ЗАБОЛЕВАНИЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PROBLEMS OF SOCIALLY SIGNIFICANT DISEASES</subject></subj-group></article-categories><title-group><article-title>Основные инструменты для измерения качества жизни у пациентов после инсульта (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Basic instruments for measuring the quality of life in patients after stroke (literature review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0745-9474</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андреев</surname><given-names>Дмитрий Анатольевич</given-names></name><name name-style="western" xml:lang="en"><surname>Andreev</surname><given-names>Dmitry A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат наук, вед. науч. сотр., ГБУ города Москвы «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента Департамента здравоохранения города Москвы», Москва, 115088, Россия</p><p>e-mail: AndreevDA@zdrav.mos.ru</p></bio><bio xml:lang="en"><p>MD, PhD, leading research, Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department, Moscow, 115088, Russian Federation</p><p>e-mail: AndreevDA@zdrav.mos.ru</p></bio><email xlink:type="simple">AndreevDA@zdrav.mos.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУ города Москвы «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента Департамента здравоохранения города Москвы»</institution></aff><aff xml:lang="en"><institution>Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>04</day><month>11</month><year>2024</year></pub-date><volume>68</volume><issue>5</issue><fpage>406</fpage><lpage>411</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Андреев Д.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Андреев Д.А.</copyright-holder><copyright-holder xml:lang="en">Andreev D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rfhealth.ru/jour/article/view/1679">https://www.rfhealth.ru/jour/article/view/1679</self-uri><abstract><p>Совершенствование лекарственной терапии привело к увеличению числа пациентов, переживших острый период инсульта. У них отмечаются такие последствия, как нарушение двигательных функций, психологические, социальные расстройства и др. Это отражается на качестве жизни (КЖ) больных. Для регистрации показателей КЖ у пациентов после инсульта применятся общие и специализированные тесты.</p><p>Цель обзора — систематизация сведений об основных опросниках, применяемых при оценке КЖ у пациентов после острого периода инсульта.</p><p>Поиск релевантных источников по теме работы проводили в базе PubMed и информационной системе Google. В поисковых запросах применяли ключевые слова: «quality of life», «stroke», «indicators» и др., названия тестов.</p><p>Собраны характеристики общих и специализированных опросников, позволяющих анализировать КЖ у пациентов после перенесённого инсульта. Резюмирована ключевая практическая информация об основных опросниках, получивших наиболее широкое распространение в зарубежной практике. Представлены сведения об их применимости в отечественных исследованиях КЖ у больных, перенёсших инсульт.</p><p>Рассмотренные тесты (общие и специализированные) обычно демонстрируют приемлемые психометрические свойства (валидность и надёжность), хотя ни один из них не является идеальным и подходящим для всех ситуаций. Продолжение поиска комплексных методов оценки КЖ у пациентов с последствиями инсульта, наилучшим образом подходящих для повседневной клинической практики, остаётся одной из важных задач медицины. Дальнейшая разработка и широкое внедрение перспективных методик анализа КЖ в регулярную медицинскую практику позволит повысить информативность оценок исходов терапии и реабилитации.</p><sec><title>Финансирование</title><p>Финансирование. Исследование не имело спонсорской поддержки. </p></sec><sec><title>Конфликт интересов</title><p>Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов в связи с публикацией данной статьи.</p></sec><sec><title>Поступила 31</title><p>Поступила 31.05.2024 / Принята к печати 03.10.2024 / Опубликована 06.11.2024</p></sec></abstract><trans-abstract xml:lang="en"><p>Improvements in drug therapy have led to an increase in the number of patients surviving after the acute period of the stroke. A significant proportion of stroke patients experience consequences such as impaired motor function, psychological and social disorders. This affects the quality of life (QoL) of patients. General and specialized tests are used to assess the QoL in patients after a stroke.</p><sec><title>The purpose of the study</title><p>The purpose of the study. Systematization of information about the main questionnaires used in assessing QoL in patients after the acute period of stroke.</p><p>The search for relevant sources devoted to the topic of work was carried out in the bibliographic database Pubmed / Medline and the Google information system. The following keywords were used in the search queries: “quality of life”, “stroke”, “indicators” etc. Test names were also used as keywords.</p><p>The characteristics of a number of general and specialized questionnaires that allow analyzing QoL in patients after a stroke are considered. Key practical information about the main questionnaires used abroad is summarized. Information on their applicability in domestic studies of QoL in patients who have suffered from a stroke is presented. The instruments that are most widely used in foreign practice are noted.</p><p>The tests reviewed (general and specific) have usually acceptable psychometric properties (validity and reliability), although none are ideal or suitable for all situations. Continuing the development of comprehensive methods for assessing QoL in patients with stroke consequences at are best suited for everyday clinical practice remains one of the important tasks of medicine.</p><p>Further development and widespread introduction of promising methods of QOL analysis into regular medical practice will increase the information content of assessments of the outcomes of therapy and rehabilitation.</p></sec><sec><title>Acknowledgment</title><p>Acknowledgment. The study had no sponsorship.</p></sec><sec><title>Conflict of interest</title><p>Conflict of interest. The authors declare the absence of obvious and potential conflicts of interest in connection with the publication of this article.</p></sec><sec><title>Received</title><p>Received: May 31, 2024 / Accepted: October 3, 2024 / Published: November 6, 2024</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>инсульт</kwd><kwd>качество жизни</kwd><kwd>тесты</kwd><kwd>опросники</kwd><kwd>анкеты</kwd><kwd>обзор</kwd></kwd-group><kwd-group xml:lang="en"><kwd>stroke</kwd><kwd>quality of life</kwd><kwd>tests</kwd><kwd>forms</kwd><kwd>questionnaires</kwd><kwd>review</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Donkor E.S. Stroke in the 21st Century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res. Treat. 2018; 2018: 3238165. https://doi.org/10.1155/2018/3238165</mixed-citation><mixed-citation xml:lang="en">Donkor E.S. Stroke in the 21st Century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res. Treat. 2018; 2018: 3238165. https://doi.org/10.1155/2018/3238165</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson W., Onuma O., Owolabi M., Sachdev S. Stroke: a global response is needed. Bull. World Health Organ. 2016; 94(9): 634–4A. https://doi.org/10.2471/BLT.16.181636</mixed-citation><mixed-citation xml:lang="en">Johnson W., Onuma O., Owolabi M., Sachdev S. Stroke: a global response is needed. Bull. World Health Organ. 2016; 94(9): 634–4A. https://doi.org/10.2471/BLT.16.181636</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chen M., Zhang Y., Dong L., Guo X. Bibliometric analysis of stroke and quality of life. Front. Neurol. 2023; 14: 1143713. https://doi.org/10.3389/fneur.2023.1143713</mixed-citation><mixed-citation xml:lang="en">Chen M., Zhang Y., Dong L., Guo X. Bibliometric analysis of stroke and quality of life. Front. Neurol. 2023; 14: 1143713. https://doi.org/10.3389/fneur.2023.1143713</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Tengs T.O., Lin T.H. A meta-analysis of quality-of-life estimates for stroke. Pharmacoeconomics. 2003; 21(3): 191–200. https://doi.org/10.2165/00019053-200321030-00004</mixed-citation><mixed-citation xml:lang="en">Tengs T.O., Lin T.H. A meta-analysis of quality-of-life estimates for stroke. Pharmacoeconomics. 2003; 21(3): 191–200. https://doi.org/10.2165/00019053-200321030-00004</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Owolabi M.O., Ogunniyi A. Profile of health-related quality of life in Nigerian stroke survivors. Eur. J. Neurol. 2009; 16(1): 54–62. https://doi.org/10.1111/j.1468-1331.2008.02339.x</mixed-citation><mixed-citation xml:lang="en">Owolabi M.O., Ogunniyi A. Profile of health-related quality of life in Nigerian stroke survivors. Eur. J. Neurol. 2009; 16(1): 54–62. https://doi.org/10.1111/j.1468-1331.2008.02339.x</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Цалта-Младенов М., Георгиева Д., Андонова С. Оценка качества жизни у лиц, перенесших инсульт. Российский неврологический журнал. 2020; 25(3): 11–6. https://doi.org/10.30629/2658-7947-2020-25-3-11-16 https://elibrary.ru/titfjp</mixed-citation><mixed-citation xml:lang="en">Tsalta-Mladenov M., Georgieva D., Andonova S. Measuring quality of life in stroke survivors. Rossiiskii nevrologicheskii zhurnal. 2020; 25(3): 11–6. https://doi.org/10.30629/2658-7947-2020-25-3-11-16 https://elibrary.ru/titfjp (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Opara J.A., Jaracz K. Quality of life of post-stroke patients and their caregivers. J. Med. Life. 2010; 3(3): 216–20.</mixed-citation><mixed-citation xml:lang="en">Opara J.A., Jaracz K. Quality of life of post-stroke patients and their caregivers. J. Med. Life. 2010; 3(3): 216–20.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Huhtakangas J.K., Saaresranta T., Huhtakangas M., Haapea M., Huhtakangas J. Thrombolysis treatment protected impairment of functional ability, quality of life and fatigue seven years after stroke. J. Stroke Cerebrovasc. Dis. 2024; 33(6): 107707. https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107707</mixed-citation><mixed-citation xml:lang="en">Huhtakangas J.K., Saaresranta T., Huhtakangas M., Haapea M., Huhtakangas J. Thrombolysis treatment protected impairment of functional ability, quality of life and fatigue seven years after stroke. J. Stroke Cerebrovasc. Dis. 2024; 33(6): 107707. https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107707</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16(3): 199–208. https://doi.org/10.1016/0168-8510(90)90421-9</mixed-citation><mixed-citation xml:lang="en">EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16(3): 199–208. https://doi.org/10.1016/0168-8510(90)90421-9</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Андреев Д.А., Завьялов А.А., Кашурников А.Ю. Базовые варианты анкеты EQ-5D - стандартные международные инструменты оценки качества жизни. Краткий обзор литературы. Здоровье мегаполиса. 2021; 2(1): 62–9. https://doi.org/10.47619/2713-2617.zm.2021.v2i1;62-69 https://elibrary.ru/xpytts</mixed-citation><mixed-citation xml:lang="en">Andreev D.A., Zavyalov A.A., Kashurnikov A.Yu. Basic versions of the eq-5d questionnaire as standard international instruments for assessing the quality of life in metropolis. Short review. Zdorov’e megapolisa. 2021; 2(1): 62–9. https://doi.org/10.47619/2713-2617.zm.2021.v2i1;62-69 https://elibrary.ru/xpytts (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Александрова Е.А., Хабибуллина А.Р. Методология оценки качества жизни, связанного со здоровьем с использованием опросника EQ-5D-3L. Российский медицинский журнал. 2019; 25(4): 202–9. https://doi.org/10.18821/0869-2106-2019-25-4-202-209 https://elibrary.ru/ytbbbt</mixed-citation><mixed-citation xml:lang="en">Aleksandrova E.A., Khabibullina A.R. Health-related quality of life measurement using EQ-5D-3L questionnaire. Rossiiskii meditsinskii zhurnal. 2019; 25(4): 202–9. https://doi.org/10.18821/0869-2106-2019-25-4-202-209 https://elibrary.ru/ytbbbt (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Devlin N., Parkin D., Janssen B. Methods for Analysing and Reporting EQ-5D Data. Cham: Springer; 2020.</mixed-citation><mixed-citation xml:lang="en">Devlin N., Parkin D., Janssen B. Methods for Analysing and Reporting EQ-5D Data. Cham: Springer; 2020.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Omelyanovskiy V., Musina N., Ratushnyak S., Bezdenezhnykh T., Fediaeva V., Roudijk B., et al. Valuation of the EQ-5D-3L in Russia. Qual. Life Res. 2021; 30(7): 1997–2007. https://doi.org/10.1007/s11136-021-02804-6</mixed-citation><mixed-citation xml:lang="en">Omelyanovskiy V., Musina N., Ratushnyak S., Bezdenezhnykh T., Fediaeva V., Roudijk B., et al. Valuation of the EQ-5D-3L in Russia. Qual. Life Res. 2021; 30(7): 1997–2007. https://doi.org/10.1007/s11136-021-02804-6</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">de Haan R., Aaronson N., Limburg M., Hewer R.L., van Crevel H. Measuring quality of life in stroke. Stroke. 1993; 24(2): 320–7. https://doi.org/10.1161/01.str.24.2.320</mixed-citation><mixed-citation xml:lang="en">de Haan R., Aaronson N., Limburg M., Hewer R.L., van Crevel H. Measuring quality of life in stroke. Stroke. 1993; 24(2): 320–7. https://doi.org/10.1161/01.str.24.2.320</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Dunderdale K., Thompson D.R., Miles J.N., Beer S.F., Furze G. Quality-of-life measurement in chronic heart failure: do we take account of the patient perspective? Eur. J. Heart Fail. 2005; 7(4): 572–82. https://doi.org/10.1016/j.ejheart.2004.06.006</mixed-citation><mixed-citation xml:lang="en">Dunderdale K., Thompson D.R., Miles J.N., Beer S.F., Furze G. Quality-of-life measurement in chronic heart failure: do we take account of the patient perspective? Eur. J. Heart Fail. 2005; 7(4): 572–82. https://doi.org/10.1016/j.ejheart.2004.06.006</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">De Sousa Peixoto R., Krstic L., Hill S.C.L., Foss A.J.E. Predicting quality of life in AMD patients-insights on the new NICE classification and on a bolt-on vision dimension for the EQ-5D. Eye (Lond). 2021; 35(12): 3333–41. https://doi.org/10.1038/s41433-021-01414-3</mixed-citation><mixed-citation xml:lang="en">De Sousa Peixoto R., Krstic L., Hill S.C.L., Foss A.J.E. Predicting quality of life in AMD patients-insights on the new NICE classification and on a bolt-on vision dimension for the EQ-5D. Eye (Lond). 2021; 35(12): 3333–41. https://doi.org/10.1038/s41433-021-01414-3</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Alomari R.A., BinMulayh E.A., Alqarni A.M., Alsobhi M., Chevidikunnan M.F., Basuodan R., et al. Trunk control and acute-phase multifactorial predictors of community mobility after stroke: a longitudinal observational study. Front. Neurol. 2024; 15: 1376444. https://doi.org/10.3389/fneur.2024.1376444</mixed-citation><mixed-citation xml:lang="en">Alomari R.A., BinMulayh E.A., Alqarni A.M., Alsobhi M., Chevidikunnan M.F., Basuodan R., et al. Trunk control and acute-phase multifactorial predictors of community mobility after stroke: a longitudinal observational study. Front. Neurol. 2024; 15: 1376444. https://doi.org/10.3389/fneur.2024.1376444</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ai W.J., Chao X., Fu J., Jiang C., Gao Y. Effects of Jiawei Yiqihuoxue decotion for the treatment of post stroke depression and anxiety. Medicine (Baltimore). 2023; 102(44): e35729. https://doi.org/10.1097/MD.0000000000035729</mixed-citation><mixed-citation xml:lang="en">Ai W.J., Chao X., Fu J., Jiang C., Gao Y. Effects of Jiawei Yiqihuoxue decotion for the treatment of post stroke depression and anxiety. Medicine (Baltimore). 2023; 102(44): e35729. https://doi.org/10.1097/MD.0000000000035729</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Skevington S.M., Lotfy M., O’Connell K.A.; WHOQOL Group. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual. Life Res. 2004; 13(2): 299–310. https://doi.org/10.1023/B:QURE.0000018486.91360.00</mixed-citation><mixed-citation xml:lang="en">Skevington S.M., Lotfy M., O’Connell K.A.; WHOQOL Group. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual. Life Res. 2004; 13(2): 299–310. https://doi.org/10.1023/B:QURE.0000018486.91360.00</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zeltzer L, Korner-Bitensky N. Stroke-Adapted Sickness Impact Profile (SA-SIP30); 2008. Available at: https://strokengine.ca/en/assessments/stroke-adapted-sickness-impact-profile-sa-sip30/</mixed-citation><mixed-citation xml:lang="en">Zeltzer L, Korner-Bitensky N. Stroke-Adapted Sickness Impact Profile (SA-SIP30); 2008. Available at: https://strokengine.ca/en/assessments/stroke-adapted-sickness-impact-profile-sa-sip30/</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">van Straten A., de Haan R.J., Limburg M., Schuling J., Bossuyt P.M., van den Bos G.A. A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30). Stroke. 1997; 28(11): 2155–61. https://doi.org/10.1161/01.str.28.11.2155</mixed-citation><mixed-citation xml:lang="en">van Straten A., de Haan R.J., Limburg M., Schuling J., Bossuyt P.M., van den Bos G.A. A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30). Stroke. 1997; 28(11): 2155–61. https://doi.org/10.1161/01.str.28.11.2155</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">van Straten A., de Haan R.J., Limburg M., van den Bos G.A. Clinical meaning of the stroke-adapted Sickness Impact Profile-30 and the Sickness Impact Profile-136. Stroke. 2000; 31(11): 2610–5. https://doi.org/10.1161/01.str.31.11.2610</mixed-citation><mixed-citation xml:lang="en">van Straten A., de Haan R.J., Limburg M., van den Bos G.A. Clinical meaning of the stroke-adapted Sickness Impact Profile-30 and the Sickness Impact Profile-136. Stroke. 2000; 31(11): 2610–5. https://doi.org/10.1161/01.str.31.11.2610</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Van de Port I.G., Ketelaar M., Schepers V.P., Van den Bos G.A., Lindeman E. Monitoring the functional health status of stroke patients: the value of the Stroke-Adapted Sickness Impact Profile-30. Disabil. Rehabil. 2004; 26(11): 635–40. https://doi.org/10.1080/09638280410001672481</mixed-citation><mixed-citation xml:lang="en">Van de Port I.G., Ketelaar M., Schepers V.P., Van den Bos G.A., Lindeman E. Monitoring the functional health status of stroke patients: the value of the Stroke-Adapted Sickness Impact Profile-30. Disabil. Rehabil. 2004; 26(11): 635–40. https://doi.org/10.1080/09638280410001672481</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Duncan P.W., Lai S.M., Tyler D., Perera S., Reker D.M., Studenski S. Evaluation of proxy responses to the Stroke Impact Scale. Stroke. 2002; 33(11): 2593–9. https://doi.org/10.1161/01.str.0000034395.06874.3e</mixed-citation><mixed-citation xml:lang="en">Duncan P.W., Lai S.M., Tyler D., Perera S., Reker D.M., Studenski S. Evaluation of proxy responses to the Stroke Impact Scale. Stroke. 2002; 33(11): 2593–9. https://doi.org/10.1161/01.str.0000034395.06874.3e</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Williams L.S., Weinberger M., Harris L.E., Clark D.O., Biller J. Development of a stroke-specific quality of life scale. Stroke. 1999; 30(7): 1362–9. https://doi.org/10.1161/01.str.30.7.1362</mixed-citation><mixed-citation xml:lang="en">Williams L.S., Weinberger M., Harris L.E., Clark D.O., Biller J. Development of a stroke-specific quality of life scale. Stroke. 1999; 30(7): 1362–9. https://doi.org/10.1161/01.str.30.7.1362</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Fong T.C.T., Lo T.L.T., Ho R.T.H. Psychometric properties of the 12-item Stroke-Specific Quality of Life Scale among stroke survivors in Hong Kong. Sci. Rep. 2023; 13(1): 1510. https://doi.org/10.1038/s41598-023-28636-7</mixed-citation><mixed-citation xml:lang="en">Fong T.C.T., Lo T.L.T., Ho R.T.H. Psychometric properties of the 12-item Stroke-Specific Quality of Life Scale among stroke survivors in Hong Kong. Sci. Rep. 2023; 13(1): 1510. https://doi.org/10.1038/s41598-023-28636-7</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Post M.W., Boosman H., van Zandvoort M.M., Passier P.E., Rinkel G.J., Visser-Meily J.M. Development and validation of a short version of the Stroke Specific Quality of Life Scale. J. Neurol. Neurosurg. Psychiatry. 2011; 82(3): 283–6. https://doi.org/10.1136/jnnp.2009.196394</mixed-citation><mixed-citation xml:lang="en">Post M.W., Boosman H., van Zandvoort M.M., Passier P.E., Rinkel G.J., Visser-Meily J.M. Development and validation of a short version of the Stroke Specific Quality of Life Scale. J. Neurol. Neurosurg. Psychiatry. 2011; 82(3): 283–6. https://doi.org/10.1136/jnnp.2009.196394</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Schuling J., de Haan R., Limburg M., Groenier K.H. The Frenchay Activities Index. Assessment of functional status in stroke patients. Stroke. 1993; 24(8): 1173–7. https://doi.org/10.1161/01.str.24.8.1173</mixed-citation><mixed-citation xml:lang="en">Schuling J., de Haan R., Limburg M., Groenier K.H. The Frenchay Activities Index. Assessment of functional status in stroke patients. Stroke. 1993; 24(8): 1173–7. https://doi.org/10.1161/01.str.24.8.1173</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ytterberg C., Cegrell L., von Koch L., Wiklander M. Depression symptoms 6 years after stroke are associated with higher perceived impact of stroke, limitations in ADL and restricted participation. Sci. Rep. 2022; 12(1): 7816. https://doi.org/10.1038/s41598-022-11097-9</mixed-citation><mixed-citation xml:lang="en">Ytterberg C., Cegrell L., von Koch L., Wiklander M. Depression symptoms 6 years after stroke are associated with higher perceived impact of stroke, limitations in ADL and restricted participation. Sci. Rep. 2022; 12(1): 7816. https://doi.org/10.1038/s41598-022-11097-9</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Cella D., Lai J.S., Nowinski C.J., Victorson D., Peterman A., Miller D., et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 2012; 78(23): 1860–7. https://doi.org/10.1212/WNL.0b013e318258f744</mixed-citation><mixed-citation xml:lang="en">Cella D., Lai J.S., Nowinski C.J., Victorson D., Peterman A., Miller D., et al. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 2012; 78(23): 1860–7. https://doi.org/10.1212/WNL.0b013e318258f744</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Hilari K., Byng S., Lamping D.L., Smith S.C. Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39): evaluation of acceptability, reliability, and validity. Stroke. 2003; 34(8): 1944–50. https://doi.org/10.1161/01.STR.0000081987.46660.ED</mixed-citation><mixed-citation xml:lang="en">Hilari K., Byng S., Lamping D.L., Smith S.C. Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39): evaluation of acceptability, reliability, and validity. Stroke. 2003; 34(8): 1944–50. https://doi.org/10.1161/01.STR.0000081987.46660.ED</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">VukoviĆ M., Sukur Ž., VukoviĆ I., Salis C., Code C. Reliability and validity of the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39) for a Serbian population. Int. J. Speech Lang. Pathol. 2022; 24(2): 168–72. https://doi.org/10.1080/17549507.2021.1971298</mixed-citation><mixed-citation xml:lang="en">VukoviĆ M., Sukur Ž., VukoviĆ I., Salis C., Code C. Reliability and validity of the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39) for a Serbian population. Int. J. Speech Lang. Pathol. 2022; 24(2): 168–72. https://doi.org/10.1080/17549507.2021.1971298</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Mitra I.H., Krishnan G. Adaptation and validation of stroke-aphasia quality of life (SAQOL-39) scale to Hindi. Ann. Indian Acad. Neurol. 2015; 18(1): 29–32. https://doi.org/10.4103/0972-2327.144276</mixed-citation><mixed-citation xml:lang="en">Mitra I.H., Krishnan G. Adaptation and validation of stroke-aphasia quality of life (SAQOL-39) scale to Hindi. Ann. Indian Acad. Neurol. 2015; 18(1): 29–32. https://doi.org/10.4103/0972-2327.144276</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmadi A., Tohidast S.A., Mansuri B., Kamali M., Krishnan G. Acceptability, reliability, and validity of the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39) across languages: a systematic review. Clin. Rehabil. 2017; 31(9): 1201–4. https://doi.org/10.1177/0269215517690017</mixed-citation><mixed-citation xml:lang="en">Ahmadi A., Tohidast S.A., Mansuri B., Kamali M., Krishnan G. Acceptability, reliability, and validity of the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39) across languages: a systematic review. Clin. Rehabil. 2017; 31(9): 1201–4. https://doi.org/10.1177/0269215517690017</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Buck D., Jacoby A., Massey A., Steen N., Sharma A., Ford G.A. Development and validation of NEWSQOL, the Newcastle Stroke-Specific Quality of Life Measure. Cerebrovasc. Dis. 2004; 17(2–3): 143–52. https://doi.org/10.1159/000075783</mixed-citation><mixed-citation xml:lang="en">Buck D., Jacoby A., Massey A., Steen N., Sharma A., Ford G.A. Development and validation of NEWSQOL, the Newcastle Stroke-Specific Quality of Life Measure. Cerebrovasc. Dis. 2004; 17(2–3): 143–52. https://doi.org/10.1159/000075783</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
